These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735 [TBL] [Abstract][Full Text] [Related]
25. [Clinical experimentation with intravenously administered disopyramide]. Vandenbosch R; Lisin N; Andriange M; Gach J; Carlier J Acta Cardiol; 1975; 30(4):267-78. PubMed ID: 1084657 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. Vismara LA; Vera Z; Miller RR; Mason DT Am J Cardiol; 1977 Jun; 39(7):1027-34. PubMed ID: 326016 [TBL] [Abstract][Full Text] [Related]
27. The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease. Sandler G J Int Med Res; 1977; 5(5):369-73. PubMed ID: 913864 [TBL] [Abstract][Full Text] [Related]
28. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237 [TBL] [Abstract][Full Text] [Related]
29. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation]. Breithardt G; Haerten K; Seipel L Z Kardiol; 1976 Aug; 65(8):713-23. PubMed ID: 61664 [TBL] [Abstract][Full Text] [Related]
30. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction. Leach AJ; Brown JE; Armstrong PW Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring. Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833 [TBL] [Abstract][Full Text] [Related]
33. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. Jennings G; Jones MS; Besterman EM; Model DG; Turner PP; Kidner PH Lancet; 1976 Jan; 1(7950):51-4. PubMed ID: 54578 [TBL] [Abstract][Full Text] [Related]
34. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction. Kus T; Sasyniuk BI J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118 [TBL] [Abstract][Full Text] [Related]
35. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation. Bennett DH Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease. Tanabe T; Takahashi K; Yoshioka K; Goto Y Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]